Negotiating High-Cost Drugs

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B. The GameChangerHHS updates the Inflation Reduction Act that will impact over 750, 000 people. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceReduced Coinsurance for Certain Part B Rebatable Drugs Under the Medicare Prescription Drug  Inflation Rebate Program HHS Announces Savings for 41 Prescription Drugs Thanks to Inflation Rebates from the Biden-Harris Administration’s Lower Cost Prescription Drug LawPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the monetary impact of the Inflation Reduction Act.2. Discuss how the Medicare Part B drug addition will benefit patients.0.05 CEU/0.5 HrUAN: 0107-0000-24-136-H04-PInitial release date: 4/08/2024Expiration date: 04/08/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram